摘要
目的观察氨基末端-B型脑钠肽前体(NT—proBNP)在急性呼吸困难鉴别诊断中的临床意义。方法用电化学发光免疫法(ECLIA)测定186例急性呼吸困难患者血浆NT—proBNP浓度,包括心源性呼吸困难(A组)和肺源性呼吸困难(B组),观察两组血浆NT—proBNP浓度。结果血浆NT—proBNP浓度在A组明显高于B组,差异有统计学意义(P〈0.01);在A组,血浆NT—proBNP浓度与左室射血分数(LVEF)呈负相关(P〈0.01)。结论NT—proBNP在急性呼吸困难鉴别诊断中有重要的临床价值。
Objective To observe the clinical value of N - terminal pro - brain natriuretic peptide(NT -proBNP)in the differential diagnosis of acute dyspnea. Methods We determined plasma NT - proBNP concentration by electricity chemiluminescence immunoassay (ECLIA) in 186 patients with acute dyspnea, who were divided into two groups: cardiac dyspnea (group A)and pulmonary dyspnea (group B). The plasma NT- proBNP concentration were compared in group A and group B. Results The plasma NT - proBNP concentration was significantly higher in group A than in group B (P 〈0.01 );in group A, the plasma NT- proBNP concentration was negatively correlated with left ventricular ejection fraction (P 〈 0. 01 ). Conclusion The plasma NT - proBNP was helpful in the differential diagnosis of acute dyspnea.
出处
《中国急救医学》
CAS
CSCD
北大核心
2012年第7期651-653,共3页
Chinese Journal of Critical Care Medicine
基金
贵州省科学技术基金资助项目(黔科合J字[2009]2206号)
关键词
急性呼吸困难
氨基末端-B型脑钠肽前体
心源性
肺源性
心力衰竭
Acute dyspnea
N -terminal pro -brain natriuretic peptide (NT -proBNP)
Cardiac dyspnea
Pulmonary dyspnea
Heart failure